Gene expression and regulation in systemic lupus erythematosus

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a significant genetic component.
• Genome-wide association studies (GWAS) have identified numerous SLE-associated loci, yet explain only a fraction of heritability.
• Gene expression serves as an intermediate phenotype, bridging genetic variation and disease manifestation.

Purpose of the Study:

• To review gene expression and regulation data in SLE.
• To identify key molecular pathways and cellular players in SLE pathogenesis.
• To explore potential therapeutic targets and the molecular basis of associated conditions.

Main Methods:

• Systematic literature review of genome-wide expression studies in SLE published since 2000.
• Analysis of gene expression patterns in peripheral blood and bone marrow mononuclear cells (BMMCs).
• Gene network analysis and examination of microRNA and DNA methylation profiles.

Main Results:

• Consistent upregulation of type I interferon signaling genes in active SLE.
• Evidence for pathogenic roles of granulocytes and myeloid cells in SLE, particularly in lupus nephritis.
• Identification of central gene regulators in BMMCs and molecular similarities between SLE and non-Hodgkin lymphoma.
• MicroRNA dysregulation contributes to SLE pathogenesis, affecting immune cell function and tissue repair.
• Alterations in white blood cell DNA methylation suggest a role for epigenetics and environmental factors.

Conclusions:

• Gene expression studies have elucidated critical pathogenic mechanisms in SLE.
• Integrated analysis of genetic, transcriptomic, and epigenomic data is crucial for molecular classification of SLE.
• Findings highlight potential therapeutic targets and deepen understanding of SLE's complex etiology.